ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cerebral Embolic Protection Devices for TAVI Market Research Report 2026
Published Date: 2026-03-31
|
Report Code: QYRE-Auto-8Q1498
Home | Market Reports | Health
Global Cerebral Embolic Protection Devices for TAVI Market Insights Forecast to 2028
BUY CHAPTERS

Global Cerebral Embolic Protection Devices for TAVI Market Research Report 2026

Code: QYRE-Auto-8Q1498
Report
2026-03-31
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boston Scientific (Claret Medical)
Venus Medtech (Keystone Heart)
Transverse Medical
Protembis GmbH
Filterlex Medical
Emboline

Cerebral Embolic Protection Devices for TAVI Market Size

The global Cerebral Embolic Protection Devices for TAVI market was valued at US$ 129 million in 2025 and is anticipated to reach US$ 453 million by 2032, at a CAGR of 19.9% from 2026 to 2032.

Cerebral Embolic Protection Devices for TAVI Market

Cerebral Embolic Protection Devices for TAVI Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cerebral Embolic Protection Devices for TAVI competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.
TAVI (transcatheter aortic valve implantation), as a minimally invasive treatment for high-risk elderly patients or patients with surgical risks, has become one of the important breakthroughs in the cardiovascular field in recent years. TAVI technology has not only significantly improved the safety and effectiveness of valve replacement therapy, but also greatly improved the quality of life of patients. However, there are certain risks in the TAVI operation, especially the risk of cerebral embolism, which has always been a challenge in clinical treatment. In order to effectively reduce the cerebral embolic events that may occur during TAVI surgery, cerebral embolic protection devices (CEPDs) came into being and became an important technical means to ensure the safety of TAVI treatment and patient prognosis.
At present, with the widespread application and acceptance of TAVI technology, the market demand for cerebral embolic protection devices is also growing. During TAVI surgery, especially when valve implantation is performed through the femoral artery, tiny blood clots may fall off due to the operation of the valve implanter and catheter, thereby causing cerebral embolism. This cerebral embolic event can cause stroke or other neurological complications, affecting the patient's prognosis. In order to effectively prevent this risk, CEPDs came into being and quickly became one of the standard configurations in TAVI surgery.
Brain
Globally, the European and American markets started early in the application of TAVI technology and related protection devices, and the market acceptance is high. Especially in the United States and Europe, more and more TAVI surgeries are beginning to routinely use cerebral embolic protection devices. In China and other Asian regions, with the gradual popularization of TAVI technology, the market demand for cerebral embolic protection devices is also rising. Although it is still in its infancy compared to the European and American markets, with the continuous advancement of medical technology and health concepts, the market potential is huge.
Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.
This report delivers a comprehensive overview of the global Cerebral Embolic Protection Devices for TAVI market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cerebral Embolic Protection Devices for TAVI. The Cerebral Embolic Protection Devices for TAVI market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cerebral Embolic Protection Devices for TAVI market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cerebral Embolic Protection Devices for TAVI manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Cerebral Embolic Protection Devices for TAVI Market Report

Report Metric Details
Report Name Cerebral Embolic Protection Devices for TAVI Market
Accounted market size in 2025 US$ 129 million
Forecasted market size in 2032 US$ 453 million
CAGR 19.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Total Artery Coverage
  • Non-total Artery Coverage
by Application
  • Hopsital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boston Scientific (Claret Medical), Venus Medtech (Keystone Heart), Transverse Medical, Emboline, Protembis GmbH, Filterlex Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Cerebral Embolic Protection Devices for TAVI manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Cerebral Embolic Protection Devices for TAVI sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Cerebral Embolic Protection Devices for TAVI Market growing?

Ans: The Cerebral Embolic Protection Devices for TAVI Market witnessing a CAGR of 19.9% during the forecast period 2026-2032.

What is the Cerebral Embolic Protection Devices for TAVI Market size in 2032?

Ans: The Cerebral Embolic Protection Devices for TAVI Market size in 2032 will be US$ 453 million.

What is the Venus Medtech (Keystone Heart) share in Cerebral Embolic Protection Devices for TAVI Market?

Ans: Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%.

Who are the main players in the Cerebral Embolic Protection Devices for TAVI Market report?

Ans: The main players in the Cerebral Embolic Protection Devices for TAVI Market are Boston Scientific (Claret Medical), Venus Medtech (Keystone Heart), Transverse Medical, Emboline, Protembis GmbH, Filterlex Medical

What are the Application segmentation covered in the Cerebral Embolic Protection Devices for TAVI Market report?

Ans: The Applications covered in the Cerebral Embolic Protection Devices for TAVI Market report are Hopsital, Others

What are the Type segmentation covered in the Cerebral Embolic Protection Devices for TAVI Market report?

Ans: The Types covered in the Cerebral Embolic Protection Devices for TAVI Market report are Total Artery Coverage, Non-total Artery Coverage

1 Cerebral Embolic Protection Devices for TAVI Market Overview
1.1 Product Definition
1.2 Cerebral Embolic Protection Devices for TAVI by Type
1.2.1 Global Cerebral Embolic Protection Devices for TAVI Market Value by Type: 2025 vs 2032
1.2.2 Total Artery Coverage
1.2.3 Non-total Artery Coverage
1.3 Cerebral Embolic Protection Devices for TAVI by Application
1.3.1 Global Cerebral Embolic Protection Devices for TAVI Market Value by Application: 2025 vs 2032
1.3.2 Hopsital
1.3.3 Others
1.4 Global Cerebral Embolic Protection Devices for TAVI Market Size Estimates and Forecasts
1.4.1 Global Cerebral Embolic Protection Devices for TAVI Revenue 2021–2032
1.4.2 Global Cerebral Embolic Protection Devices for TAVI Sales 2021–2032
1.4.3 Global Cerebral Embolic Protection Devices for TAVI Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Cerebral Embolic Protection Devices for TAVI Market Competition by Manufacturers
2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cerebral Embolic Protection Devices for TAVI Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cerebral Embolic Protection Devices for TAVI, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cerebral Embolic Protection Devices for TAVI, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cerebral Embolic Protection Devices for TAVI, Product Types and Applications
2.7 Global Key Manufacturers of Cerebral Embolic Protection Devices for TAVI, Date of Entry into the Industry
2.8 Global Cerebral Embolic Protection Devices for TAVI Market Competitive Situation and Trends
2.8.1 Global Cerebral Embolic Protection Devices for TAVI Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cerebral Embolic Protection Devices for TAVI Players Market Share by Revenue
2.8.3 Global Cerebral Embolic Protection Devices for TAVI Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cerebral Embolic Protection Devices for TAVI Market Scenario by Region
3.1 Global Cerebral Embolic Protection Devices for TAVI Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cerebral Embolic Protection Devices for TAVI Sales by Region: 2021–2032
3.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Region: 2021–2026
3.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales by Region: 2027–2032
3.3 Global Cerebral Embolic Protection Devices for TAVI Revenue by Region: 2021–2032
3.3.1 Global Cerebral Embolic Protection Devices for TAVI Revenue by Region: 2021–2026
3.3.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Region: 2027–2032
3.4 North America Cerebral Embolic Protection Devices for TAVI Market Facts & Figures by Country
3.4.1 North America Cerebral Embolic Protection Devices for TAVI Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cerebral Embolic Protection Devices for TAVI Sales by Country (2021–2032)
3.4.3 North America Cerebral Embolic Protection Devices for TAVI Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cerebral Embolic Protection Devices for TAVI Market Facts & Figures by Country
3.5.1 Europe Cerebral Embolic Protection Devices for TAVI Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cerebral Embolic Protection Devices for TAVI Sales by Country (2021–2032)
3.5.3 Europe Cerebral Embolic Protection Devices for TAVI Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cerebral Embolic Protection Devices for TAVI Market Facts & Figures by Region
3.6.1 Asia Pacific Cerebral Embolic Protection Devices for TAVI Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales by Region (2021–2032)
3.6.3 Asia Pacific Cerebral Embolic Protection Devices for TAVI Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cerebral Embolic Protection Devices for TAVI Market Facts & Figures by Country
3.7.1 Latin America Cerebral Embolic Protection Devices for TAVI Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cerebral Embolic Protection Devices for TAVI Sales by Country (2021–2032)
3.7.3 Latin America Cerebral Embolic Protection Devices for TAVI Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cerebral Embolic Protection Devices for TAVI Market Facts & Figures by Country
3.8.1 Middle East and Africa Cerebral Embolic Protection Devices for TAVI Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cerebral Embolic Protection Devices for TAVI Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cerebral Embolic Protection Devices for TAVI Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Type (2021–2032)
4.1.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Type (2021–2026)
4.1.2 Global Cerebral Embolic Protection Devices for TAVI Sales by Type (2027–2032)
4.1.3 Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Type (2021–2032)
4.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Type (2021–2032)
4.2.1 Global Cerebral Embolic Protection Devices for TAVI Revenue by Type (2021–2026)
4.2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Type (2027–2032)
4.2.3 Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Type (2021–2032)
4.3 Global Cerebral Embolic Protection Devices for TAVI Price by Type (2021–2032)
5 Segment by Application
5.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Application (2021–2032)
5.1.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Application (2021–2026)
5.1.2 Global Cerebral Embolic Protection Devices for TAVI Sales by Application (2027–2032)
5.1.3 Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Application (2021–2032)
5.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Application (2021–2032)
5.2.1 Global Cerebral Embolic Protection Devices for TAVI Revenue by Application (2021–2026)
5.2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Application (2027–2032)
5.2.3 Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Application (2021–2032)
5.3 Global Cerebral Embolic Protection Devices for TAVI Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific (Claret Medical)
6.1.1 Boston Scientific (Claret Medical) Company Information
6.1.2 Boston Scientific (Claret Medical) Description and Business Overview
6.1.3 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.1.5 Boston Scientific (Claret Medical) Recent Developments/Updates
6.2 Venus Medtech (Keystone Heart)
6.2.1 Venus Medtech (Keystone Heart) Company Information
6.2.2 Venus Medtech (Keystone Heart) Description and Business Overview
6.2.3 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.2.5 Venus Medtech (Keystone Heart) Recent Developments/Updates
6.3 Transverse Medical
6.3.1 Transverse Medical Company Information
6.3.2 Transverse Medical Description and Business Overview
6.3.3 Transverse Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Transverse Medical Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.3.5 Transverse Medical Recent Developments/Updates
6.4 Emboline
6.4.1 Emboline Company Information
6.4.2 Emboline Description and Business Overview
6.4.3 Emboline Cerebral Embolic Protection Devices for TAVI Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Emboline Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.4.5 Emboline Recent Developments/Updates
6.5 Protembis GmbH
6.5.1 Protembis GmbH Company Information
6.5.2 Protembis GmbH Description and Business Overview
6.5.3 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.5.5 Protembis GmbH Recent Developments/Updates
6.6 Filterlex Medical
6.6.1 Filterlex Medical Company Information
6.6.2 Filterlex Medical Description and Business Overview
6.6.3 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.6.5 Filterlex Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cerebral Embolic Protection Devices for TAVI Industry Chain Analysis
7.2 Cerebral Embolic Protection Devices for TAVI Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cerebral Embolic Protection Devices for TAVI Production Mode & Process Analysis
7.4 Cerebral Embolic Protection Devices for TAVI Sales and Marketing
7.4.1 Cerebral Embolic Protection Devices for TAVI Sales Channels
7.4.2 Cerebral Embolic Protection Devices for TAVI Distributors
7.5 Cerebral Embolic Protection Devices for TAVI Customer Analysis
8 Cerebral Embolic Protection Devices for TAVI Market Dynamics
8.1 Cerebral Embolic Protection Devices for TAVI Industry Trends
8.2 Cerebral Embolic Protection Devices for TAVI Market Drivers
8.3 Cerebral Embolic Protection Devices for TAVI Market Challenges
8.4 Cerebral Embolic Protection Devices for TAVI Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Boston Scientific (Claret Medical)
Venus Medtech (Keystone Heart)
Transverse Medical
Protembis GmbH
Filterlex Medical
Emboline
List of Tables
 Table 1. Global Cerebral Embolic Protection Devices for TAVI Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Cerebral Embolic Protection Devices for TAVI Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Cerebral Embolic Protection Devices for TAVI Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Cerebral Embolic Protection Devices for TAVI Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Cerebral Embolic Protection Devices for TAVI Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Cerebral Embolic Protection Devices for TAVI Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Cerebral Embolic Protection Devices for TAVI Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Cerebral Embolic Protection Devices for TAVI, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Cerebral Embolic Protection Devices for TAVI, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Cerebral Embolic Protection Devices for TAVI, Product Types and Applications
 Table 12. Global Key Manufacturers of Cerebral Embolic Protection Devices for TAVI, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cerebral Embolic Protection Devices for TAVI Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cerebral Embolic Protection Devices for TAVI Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cerebral Embolic Protection Devices for TAVI Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Cerebral Embolic Protection Devices for TAVI Sales by Region (Units), 2021–2026
 Table 18. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Region (2021–2026)
 Table 19. Global Cerebral Embolic Protection Devices for TAVI Sales by Region (Units), 2027–2032
 Table 20. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Region (2027–2032)
 Table 21. Global Cerebral Embolic Protection Devices for TAVI Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Region (2021–2026)
 Table 23. Global Cerebral Embolic Protection Devices for TAVI Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Region (2027–2032)
 Table 25. North America Cerebral Embolic Protection Devices for TAVI Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Cerebral Embolic Protection Devices for TAVI Sales by Country (Units), 2021–2026
 Table 27. North America Cerebral Embolic Protection Devices for TAVI Sales by Country (Units), 2027–2032
 Table 28. North America Cerebral Embolic Protection Devices for TAVI Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Cerebral Embolic Protection Devices for TAVI Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Cerebral Embolic Protection Devices for TAVI Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Cerebral Embolic Protection Devices for TAVI Sales by Country (Units), 2021–2026
 Table 32. Europe Cerebral Embolic Protection Devices for TAVI Sales by Country (Units), 2027–2032
 Table 33. Europe Cerebral Embolic Protection Devices for TAVI Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Cerebral Embolic Protection Devices for TAVI Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Cerebral Embolic Protection Devices for TAVI Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Cerebral Embolic Protection Devices for TAVI Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Cerebral Embolic Protection Devices for TAVI Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Cerebral Embolic Protection Devices for TAVI Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Cerebral Embolic Protection Devices for TAVI Sales by Country (Units), 2021–2026
 Table 42. Latin America Cerebral Embolic Protection Devices for TAVI Sales by Country (Units), 2027–2032
 Table 43. Latin America Cerebral Embolic Protection Devices for TAVI Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Cerebral Embolic Protection Devices for TAVI Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Cerebral Embolic Protection Devices for TAVI Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Cerebral Embolic Protection Devices for TAVI Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Cerebral Embolic Protection Devices for TAVI Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Cerebral Embolic Protection Devices for TAVI Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Cerebral Embolic Protection Devices for TAVI Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Cerebral Embolic Protection Devices for TAVI Sales (Units) by Type (2021–2026)
 Table 51. Global Cerebral Embolic Protection Devices for TAVI Sales (Units) by Type (2027–2032)
 Table 52. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Type (2021–2026)
 Table 53. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Type (2027–2032)
 Table 54. Global Cerebral Embolic Protection Devices for TAVI Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Cerebral Embolic Protection Devices for TAVI Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Type (2021–2026)
 Table 57. Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Type (2027–2032)
 Table 58. Global Cerebral Embolic Protection Devices for TAVI Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Cerebral Embolic Protection Devices for TAVI Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Cerebral Embolic Protection Devices for TAVI Sales (Units) by Application (2021–2026)
 Table 61. Global Cerebral Embolic Protection Devices for TAVI Sales (Units) by Application (2027–2032)
 Table 62. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Application (2021–2026)
 Table 63. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share by Application (2027–2032)
 Table 64. Global Cerebral Embolic Protection Devices for TAVI Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Cerebral Embolic Protection Devices for TAVI Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Application (2021–2026)
 Table 67. Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Application (2027–2032)
 Table 68. Global Cerebral Embolic Protection Devices for TAVI Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Cerebral Embolic Protection Devices for TAVI Price (US$/Unit) by Application (2027–2032)
 Table 70. Boston Scientific (Claret Medical) Company Information
 Table 71. Boston Scientific (Claret Medical) Description and Business Overview
 Table 72. Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Product
 Table 74. Boston Scientific (Claret Medical) Recent Developments/Updates
 Table 75. Venus Medtech (Keystone Heart) Company Information
 Table 76. Venus Medtech (Keystone Heart) Description and Business Overview
 Table 77. Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Product
 Table 79. Venus Medtech (Keystone Heart) Recent Developments/Updates
 Table 80. Transverse Medical Company Information
 Table 81. Transverse Medical Description and Business Overview
 Table 82. Transverse Medical Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Transverse Medical Cerebral Embolic Protection Devices for TAVI Product
 Table 84. Transverse Medical Recent Developments/Updates
 Table 85. Emboline Company Information
 Table 86. Emboline Description and Business Overview
 Table 87. Emboline Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Emboline Cerebral Embolic Protection Devices for TAVI Product
 Table 89. Emboline Recent Developments/Updates
 Table 90. Protembis GmbH Company Information
 Table 91. Protembis GmbH Description and Business Overview
 Table 92. Protembis GmbH Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Protembis GmbH Cerebral Embolic Protection Devices for TAVI Product
 Table 94. Protembis GmbH Recent Developments/Updates
 Table 95. Filterlex Medical Company Information
 Table 96. Filterlex Medical Description and Business Overview
 Table 97. Filterlex Medical Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Filterlex Medical Cerebral Embolic Protection Devices for TAVI Product
 Table 99. Filterlex Medical Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Cerebral Embolic Protection Devices for TAVI Distributors List
 Table 103. Cerebral Embolic Protection Devices for TAVI Customers List
 Table 104. Cerebral Embolic Protection Devices for TAVI Market Trends
 Table 105. Cerebral Embolic Protection Devices for TAVI Market Drivers
 Table 106. Cerebral Embolic Protection Devices for TAVI Market Challenges
 Table 107. Cerebral Embolic Protection Devices for TAVI Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cerebral Embolic Protection Devices for TAVI
 Figure 2. Global Cerebral Embolic Protection Devices for TAVI Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Cerebral Embolic Protection Devices for TAVI Market Share by Type: 2025 & 2032
 Figure 4. Total Artery Coverage Product Picture
 Figure 5. Non-total Artery Coverage Product Picture
 Figure 6. Global Cerebral Embolic Protection Devices for TAVI Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Cerebral Embolic Protection Devices for TAVI Market Share by Application: 2025 & 2032
 Figure 8. Hopsital
 Figure 9. Others
 Figure 10. Global Cerebral Embolic Protection Devices for TAVI Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Cerebral Embolic Protection Devices for TAVI Market Size (US$ Million), 2021–2032
 Figure 12. Global Cerebral Embolic Protection Devices for TAVI Sales (Units), 2021–2032
 Figure 13. Global Cerebral Embolic Protection Devices for TAVI Average Price (US$/Unit), 2021–2032
 Figure 14. Cerebral Embolic Protection Devices for TAVI Report Years Considered
 Figure 15. Cerebral Embolic Protection Devices for TAVI Sales Share by Manufacturers in 2025
 Figure 16. Global Cerebral Embolic Protection Devices for TAVI Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Cerebral Embolic Protection Devices for TAVI Players: Market Share by Revenue in Cerebral Embolic Protection Devices for TAVI in 2025
 Figure 18. Cerebral Embolic Protection Devices for TAVI Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Cerebral Embolic Protection Devices for TAVI Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Cerebral Embolic Protection Devices for TAVI Sales Market Share by Country (2021–2032)
 Figure 21. North America Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Country (2021–2032)
 Figure 22. United States Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Cerebral Embolic Protection Devices for TAVI Sales Market Share by Country (2021–2032)
 Figure 25. Europe Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Region (2021–2032)
 Figure 33. China Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Indonesia Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Thailand Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Malaysia Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Cerebral Embolic Protection Devices for TAVI Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Cerebral Embolic Protection Devices for TAVI Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Cerebral Embolic Protection Devices for TAVI Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Cerebral Embolic Protection Devices for TAVI by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Cerebral Embolic Protection Devices for TAVI by Type (2021–2032)
 Figure 54. Global Cerebral Embolic Protection Devices for TAVI Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Cerebral Embolic Protection Devices for TAVI by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Cerebral Embolic Protection Devices for TAVI by Application (2021–2032)
 Figure 57. Global Cerebral Embolic Protection Devices for TAVI Price (US$/Unit) by Application (2021–2032)
 Figure 58. Cerebral Embolic Protection Devices for TAVI Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Transcatheter Aortic Valve System Market Research Report 2025
Global Transcatheter Aortic Valve Replacement TAVR Market Research Report 2025
Global Transcatheter Aortic Valve Replacement Service Market Research Report 2024
Global Transcatheter Aortic Valve Implantation TAVI Market Insights Forecast to 2030
Global Valvular Disease Interventional Device Market Research Report 2025
Global Transcatheter Aortic Valve Market Research Report 2024
Global Transcatheter Heart Valve Therapies Market Research Report 2024
Global Valvular Disease Device Market Research Report 2025
Global Aortic Valve Device Market Research Report 2025
Global Transcatheter Aortic Heart Valve Device Market Research Report 2024
Global Transcathetar Devices Market Research Report 2024
Global Transcatheter Heart Valve Replacement and Repair Market Insights Forecast to 2030
Global Aortic Valve Products Market Research Report 2025
Transcatheter Aortic Valve Replacement Tubing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transcatheter Aortic Valve Implantation TAVI System Market Research Report 2025
Global Cerebral Embolic Protection Devices for TAVR Market Research Report 2025
Global Transcatheter Mitral Valve Treatment Devices Market Research Report 2024
Transcatheter Pulmonary Valve Replacement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transcatheter Tricuspid Valve Replacement TTVR Technology Market Research Report 2024
Brain Protection Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions